Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Profit After Tax (2018 - 2025)

Historic Profit After Tax for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to -$21.0 million.

  • Neurogene's Profit After Tax fell 364.05% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$85.1 million, marking a year-over-year decrease of 10280.64%. This contributed to the annual value of -$75.1 million for FY2024, which is 10691.14% down from last year.
  • As of Q3 2025, Neurogene's Profit After Tax stood at -$21.0 million, which was down 364.05% from -$22.0 million recorded in Q2 2025.
  • Neurogene's 5-year Profit After Tax high stood at $13.7 million for Q4 2023, and its period low was -$22.6 million during Q1 2025.
  • Its 3-year average for Profit After Tax is -$15.1 million, with a median of -$18.5 million in 2024.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 24291.78% in 2024, then crashed by 364.05% in 2025.
  • Neurogene's Profit After Tax (Quarter) stood at $13.7 million in 2023, then crashed by 242.92% to -$19.5 million in 2024, then decreased by 7.37% to -$21.0 million in 2025.
  • Its last three reported values are -$21.0 million in Q3 2025, -$22.0 million for Q2 2025, and -$22.6 million during Q1 2025.